Intellectual Property India Publishes Patent Application for 'Integrated In Silico And In Vitro Approaches For Identification, Structural Modeling, And Drug Validation Of A Novel Chrna3 Antigenic Peptide For Targeted Lung Cancer Therapy' Filed by Ezhilmani M

MUMBAI, India, April 17 -- Intellectual Property India has published a patent application (202641022278 A) filed by Ezhilmani M, Chennai, Tamil Nadu, on Feb. 25, for 'integrated in silico and in vitro approaches for identification, structural modeling, and drug validation of a novel chrna3 antigenic peptide for targeted lung cancer therapy.'

Inventor(s) include Ezhilmani M.

The application for the patent was published on April 17, under issue no. 16/2026.

According to the abstract released by the Intellectual Property India: "Lung cancer remains the Leading cause of global cancer mortality, Largely due to Latestage detection and the urgent need for precision-based therapeutic strategies. A key factor in this challenge is the Cholinergic ...